Small Cell Lung Cancer Recurrent
9 clinical trials · Condition
◉ Watch Small Cell Lung Cancer Recurrent
| Record | Firm | Date |
|---|---|---|
| KRT-232 in Subjects With Relapsed or Refractory Small Cell Lung Cancer (NCT05027867) | Kartos Therapeutics, Inc. | 2021-12-06 |
| Assessing Safety and Efficacy of Sintilimab and Metformin Combination Therapy in SCLC (NCT03994744) | Hunan Cancer Hospital | 2019-08-20 |
| S1 Plus Anlotinib in Treating Patients With Refractory or Relapsed Small-cell Lung Cancer (NCT03823118) | Taizhou Hospital | 2019-03-01 |
| Sequential Hypofractionated Radiotherapy Followed by Anti-PD-L1 Atezolizumab for SCLC (NCT03262454) | National Cancer Center, Korea | 2018-01-22 |
| Temozolomide in Patients Affected by Relapsed Sensitive or Refractory Small Cell Lung Cancer With MGMT Methylation (NCT02477813) | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | 2015-01-01 |
| BIBF 1120 as Second Line Treatment for Small Cell Lung Cancer (NCT01441297) | Ji-youn Han | 2011-12-01 |
Track Small Cell Lung Cancer Recurrent automatically
Every clearance here is in the API, with alerts when new ones post.